What is the expected outcome of clinical trials as per ICH E6(R3) Guideline?

• A. Clinical trials should generate reliable results.
• B. Trials should be completed within six months.
• C. Trials should prove the treatment works in all populations.
• D. Trials should produce no data.

Answer: (A)

The main concept tested is that the goal of GCP-compliant clinical trials is to generate reliable results that accurately reflect safety and efficacy for making sound regulatory and patient-care decisions. ICH E6(R3) emphasizes quality in all aspects of trial conduct—design, conduct, data collection, and reporting—to ensure the data are credible, complete, and verifiable. When trials are conducted with proper safeguards, monitoring, and documentation, the results become trustworthy enough to support decision-making about a treatment’s risk-benefit profile. That is why generating reliable results is the best-fitting outcome.

The other options don’t align with the guideline’s purpose. There isn’t a universal six-month deadline in ICH E6(R3); trial durations vary by protocol and disease area, and timeliness is not the defining goal. It’s also not required to show that a treatment works in every population studied—trials are designed to assess safety and efficacy in predefined populations, and generalizability is addressed through study design and subsequent analyses, not guaranteed for all groups. Producing no data would defeat the whole purpose of conducting a trial, which is to collect information to inform benefit-risk decisions.